Home Tags Disitamab vedotin

Tag: disitamab vedotin

U.S. FDA Grants Breakthrough Therapy Designation for Disitamab Vedotin in Urothelial...

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for disitamab vedotin (previously known as RC48), for the second-line treatment of...

Disitamab Vedotin Shows Clinically Meaningful Response and Survival Benefit in Heavily...

Data from a phase II study of disitamab vedotin (previously known as RC48) shows clinically meaningful results in the treatment of heavily pretreated patients...